公开(公告)号：US10441551B2

公开(公告)日：2019-10-15

申请号：US15769393

申请日：2016-10-24

Applicant: HISAMITSU PHARMACEUTICAL CO., INC.

Inventor： Atsushi Sonobe ,  Akio Takeuchi ,  Yasunori Takada

IPC: A61K9/70 ,  A61K47/02 ,  A61K47/10 ,  A61K47/14 ,  A61K47/20 ,  A61K47/22 ,  A61K47/32 ,  A61K47/44 ,  A61K31/4468

Abstract: A patch comprises a backing and an adhesive layer laminated on at least one surface of the backing, in which the adhesive layer contains at least one selected from the group consisting of fentanyl and salts thereof, and contains an adhesive base material and an antioxidant having a sulfur atom in its molecule.

公开(公告)号：US20140271796A1

公开(公告)日：2014-09-18

申请号：US14354151

申请日：2012-10-23

Applicant: HISAMITSU PHARMACEUTICAL CO., INC.

Inventor： Kenji Atarashi ,  Kazuhiro Suzuki ,  Akio Takeuchi ,  Hidekazu Kuma

IPC: A61K31/575 ,  A61K31/235 ,  A61K9/70

CPC classification number: A61K31/575 ,  A61F2013/00646 ,  A61F2013/00906 ,  A61K9/0014 ,  A61K9/7023 ,  A61K9/7038 ,  A61K9/7053 ,  A61K9/7061 ,  A61K9/7084 ,  A61K9/7092 ,  A61K31/216 ,  A61K31/235 ,  A61K36/00 ,  A61K47/28 ,  A61K2300/00

Abstract: A transdermal absorption preparation containing at least one drug selected from oxybutynin and pharmaceutically acceptable salts thereof and 0.05% by mass or more of a sterol selected from cholesterols, cholesterol derivatives and cholesterol analogs, relative to a total amount of the transdermal absorption preparation.

Abstract translation: 相对于经皮吸收制剂的总量，含有选自奥昔布宁及其药学上可接受的盐中的至少一种药物和0.05质量％以上选自胆固醇，胆固醇衍生物和胆固醇类似物的固醇的透皮吸收制剂。